scholarly journals Study on resected cases of hilar bile duct carcinoma in terms of the status of lymph node metastasis.

2002 ◽  
Vol 63 (2) ◽  
pp. 306-310
Author(s):  
Tadanori ISHIKAWA ◽  
Tadashi HORIMI ◽  
Takahiro OKABAYASHI ◽  
Junichi ICHIKAWA ◽  
Yutaka NISHIOKA ◽  
...  
Keyword(s):  
Lymph Node ◽  
Bile Duct ◽  
Lymph Node Metastasis ◽  
Bile Duct Carcinoma ◽  
Duct Carcinoma ◽  
Node Metastasis ◽  
Hilar Bile Duct Carcinoma ◽  
The Status ◽  
Hilar Bile Duct

Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma

2006 ◽  
Vol 32 (2) ◽  
pp. 208-212 ◽  
Author(s):  
K. Taniguchi ◽  
M. Tabata ◽  
T. Iida ◽  
T. Hori ◽  
S. Yagi ◽  
...  
Keyword(s):  
Lymph Node ◽  
Bile Duct ◽  
Bile Duct Carcinoma ◽  
Duct Carcinoma ◽  
Lymph Node Micrometastasis ◽  
Hilar Bile Duct Carcinoma ◽  
Hilar Bile Duct

High-dose remote afterloading intraluminal brachytherapy in the treatment of unresectable hilar or upper bile duct carcinoma.

2011 ◽  
Vol 29 (4_suppl) ◽  
pp. 273-273
Author(s):  
H. Andoh ◽  
Y. Shindo
Keyword(s):  
Lymph Node ◽  
Bile Duct ◽  
Lymph Node Metastasis ◽  
Median Survival ◽  
Bile Duct Carcinoma ◽  
Survival Rates ◽  
High Dose ◽  
Duct Carcinoma ◽  
Node Metastasis ◽  
Group I

273 Background: To evaluate intraluminal brachytherapy (ILBT) for the treatment of unresectable hilar or upper bile duct carcinoma. Methods: Between 1992 and 2005, 48 patients were identified who were not indicated for surgical resections. Among them, 22 patients received only biliary drainage (group I) and 26 patients received ILBT (group II). Expandable metallic stents (EMSs) were used in 17 patients and ILBT was delivered using the Varisource 200 remote afterloading unit with a 10 Ci 192Ir or 60Co. Each treatment of ILBT delivered 6 Gy at a 1-cm depth, and was repeated weekly for 5 weeks. A total of 30 Gy was administered to each patient. Survival rates between the groups were compared using Kaplan-Meier survival curves. Results: In group I, survival rates at 6 and 12 months were 9% and 0%, respectively. Median survival was only 2 months. In contrast, group II survival rates at 6, 12, and 24 months were 77%, 54%, and 9%, respectively, and the median survival of this group was 13 months. Improved survival with the use of ILBT was significant, particularly in clinical stages III, IVa (p<0.01), and IVb (p<0.05). ILBT helped keep the bile duct lumen patent for a long period, but was not effective for the treatment of patients with positive lymph node metastasis. Conclusions: Although randomized controlled studies will be necessary, the results of the present study are encouraging for using high-dose ILBT in the treatment of unresectable hilar or upper bile duct carcinoma without lymph node metastasis. No significant financial relationships to disclose.

scholarly journals A Case of Hilar Bile Duct Carcinoma with Intraductal Papillary Growth arising from Peribiliary Bile Gland of the Left Hepatic Duct

2007 ◽  
Vol 40 (2) ◽  
pp. 180-185 ◽  
Author(s):  
Hidenori Karasaki ◽  
Kazunori Watanabe ◽  
Daitaro Yoshikawa ◽  
Shigetaka Suzuki ◽  
Akira Ishizaki ◽  
...  
Keyword(s):  
Bile Duct ◽  
Hepatic Duct ◽  
Bile Duct Carcinoma ◽  
Left Hepatic Duct ◽  
Duct Carcinoma ◽  
Hilar Bile Duct Carcinoma ◽  
Hilar Bile Duct ◽  
Papillary Growth

scholarly journals The Pattern of Infiltration at the Proximal Border of Hilar Bile Duct Carcinoma

1998 ◽  
Vol 227 (3) ◽  
pp. 405-411 ◽  
Author(s):  
Eiji Sakamoto ◽  
Yuji Nimura ◽  
Naokazu Hayakawa ◽  
Junichi Kamiya ◽  
Satoshi Kondo ◽  
...  
Keyword(s):  
Bile Duct ◽  
Bile Duct Carcinoma ◽  
Duct Carcinoma ◽  
Hilar Bile Duct Carcinoma ◽  
Hilar Bile Duct ◽  
Proximal Border

scholarly journals Hilar Bile Duct Carcinoma with Superficial Spread to the Duodenal Side of the Common Bile Duct: Report of Two Cases

2004 ◽  
Vol 37 (5) ◽  
pp. 562-567
Author(s):  
Naomasa Uesugi ◽  
Katsura Tanzan ◽  
Eiichiro Yamaguchi ◽  
Takashi Nakamura ◽  
Motohiro Takesige ◽  
...  
Keyword(s):  
Bile Duct ◽  
Common Bile Duct ◽  
Bile Duct Carcinoma ◽  
Duct Carcinoma ◽  
Hilar Bile Duct Carcinoma ◽  
Hilar Bile Duct ◽  
The Common ◽  
Superficial Spread

Multiple Stenting in Hilar Bile Duct Carcinoma: Three-Branched Partial Stent-in-Stent Deployment with the JOSTENT SelfX

Endoscopy ◽  
2004 ◽  
Vol 36 (9) ◽  
pp. 829-830 ◽  
Author(s):  
H. Kawamoto ◽  
E. Ishida ◽  
T. Ogawa ◽  
Y. Okamoto ◽  
H. Okazaki ◽  
...  
Keyword(s):  
Bile Duct ◽  
Bile Duct Carcinoma ◽  
Stent Deployment ◽  
Duct Carcinoma ◽  
Hilar Bile Duct Carcinoma ◽  
Hilar Bile Duct
Sign in / Sign up

Export Citation Format

Share Document